Human erythropoietin receptor increases GATA-2 and Bcl-x(L) by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2

Cell Growth and Differentiation

Volumn 8, Issue 12, 1997, Pages 1317-1328

  Tsushima, Hideki ^a   Urata, Yoshishige ^a   Miyazaki, Yasushi ^a   Fuchigami, Kengo ^a   Kuriyama, Kazutaka ^a   Kondo, Takahito ^a   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; COMPLEMENTARY DNA; DNA FRAGMENT; ENZYME INHIBITOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; MESSENGER RNA; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; NUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ERYTHROID CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BCL-X PROTEIN; CELL DIFFERENTIATION; CELL DIVISION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ERYTHROPOIETIN; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UP-REGULATION;

MAMMALIA;

EID: 0031471010     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Kranz, S. B. Erythropoietin. Blood, 77: 419-434, 1991.
2. Youssoufian, H., Longmore, G., Neumann, D., Yoshimura, A., and Lodish, H. F. Structure, function, and activation of the erythropoietin receptor. Blood, 81: 2223-2236, 1993.
3. Kishimoto, T., Taga, T., and Akira, S. Cytokine signal transduction. Cell, 76: 253-262, 1994.
4. ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells. J. Biol. Chem., 267: 8293-8298, 1992.
5. Miura, Y., Miura, O., Ihle, J. N., and Aoki, N. Activation of the mitogen-activated protein kinase pathways by the erythropoietin receptor. J. Biol. Chem., 269: 29962-29969, 1994.
6. Ren, H-Y., Komatsu, N., Shimizu, R., Okada, K., and Miura, Y. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-γ1 in a human erythropoietin-dependent cell line. J. Biol. Chem., 269: 19633-19638, 1994.
7. Miura, O., Nakamura, N., Ihle, J. N., and Aoki, N. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J. Biol. Chem., 269: 614-620, 1994.
8. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., and Ihle, J. N. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell, 74: 227-236, 1993.
9. Wakao, H., Harada, N., Kitamura, T., Mui, A. L. F., and Miyajima, A. Ilnterleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J., 14: 2527-2535, 1995.
10. Pallard, C., Gouilleux, F., Charon, M., Groner, B., Gisselbrecht, S., and Dusanter-Fourt, I. lnterleukin-3, erythropoietin, and prolactin activate a STA5-like factor in lymphoid cells. J. Biol. Chem., 270: 15942-15945, 1995.
11. Spangler, R., Bailey, S. C., and Sytkowski, A. J. Erythropoietin increases c-myc mRNA by a protein kinase C-dependent pathway. J. Biol. Chem., 266: 681-684, 1991.
12. Chem, Y., Spangler, R., Choi, H-S., and Sytkowski, A. J. Erythropoietin activates the receptor in both Rauscher and Friend murine erythroleukemia cells. J. Biol. Chem., 266: 2009-2012, 1991.
13. Patel, H. R., and Sytkowski, A. J. Erythropoietin activation of AP1 (Fos/Jun). Exp. Hematol., 23: 619-625, 1995.
14. L and Bcl-2. Blood, 88: 1576-1582, 1996.
15. Yang, E., and Korsmeyer, S. J. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88: 386-401, 1996.
16. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., and Miyajima, A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J., 14: 2816-2826, 1995.
17. Wu, H., Liu, X., Jaenisch, R., and Lodish, H. F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell, 83: 59-67, 1995.
18. Lin, C-S., Lim, S-K., D'Agati, V., and Costantini, F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev., 10: 154-164, 1996.
19. Kieran, M. W., Perkins, A. C., Orkin, S. H., and Zon, L. I. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryo lacking the erythropoietin receptor. Proc. Natl. Acad. Sci. USA, 93: 9126-9131, 1996.
20. Miyazaki, Y., Kuriyama K., Higuchi, M., Tsushima, H., Sohda, H., Imai, N., Saito, M., Kondo, T., and Tomonaga, M. Establishment and characterization of a new erythropoietin dependent acute myeloid cell line, AS-E2. Leukemia (Baltimore), in press, 1997.
21. Jones, S. S., D'Andrea, A. D., Haines, L. L, and Wong, G. G. Human erythropoietin receptor: cloning, expression, and biologic characterization. Blood, 76: 31-35, 1990.
22. Nakamura, Y., Komatsu, N., and Nakauchi, H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science (Washington DC), 257: 1138-1141, 1992.
23. Nagata, N. Apoptosis by death factor. Cell, 88: 355-365, 1997.
24. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., and Aunins, J. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature (Lond.), 356: 768-774, 1992.
25. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T-T., Yu, V. L., and Miller, D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
26. Dolle, R. E., Hoyer, D., Prasad, C. V., Schmidt, S. J., Helazek, C. T., Miller, R. E., and Ator, M. A. P1 aspartate-based α((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1 β-converting enzyme. J. Med. Chem., 37: 563-564, 1994.
27. Mashima, T., Naito, M., Kataoka, S., Kawai, H., and Tsuruo, T. Aspartate-based inhibitor of interleukin-1 β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 Cells. Biochem. Biophys. Res. Commun., 209: 907-915, 1995.
28. Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., and Thompson, C. B. bcl-X, a (bcl-2-related gene that functions as a dominant regulator of apoptic cell death. Cell, 74: 597-608, 1993.
29. Akiyama, T., Ishida, J., Nakagawa, S., Ogawa, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592-5595, 1987.
30. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem., 269: 3563-3567, 1994.
31. Nishizuka, Y. Turnover of inositol phospholipids and signal transduction. Science (Washington DC), 225: 1365-1370, 1984.
32. Hug, H., and Sarre, T. F. Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J., 291: 329-343, 1993.
33. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry, 23: 5036-5041, 1984.
34. Chiba, T., Nagata, Y., Kishi, A., Sakamaki, K., Miyajima, A., Yamamoto, M., Engel, J. D., and Todokoro, K. Induction of erythroid-specific gene expression in lymphoid cells. Proc. Natl. Acad. Sci. USA, 90: 11593-11597, 1993.
35. Palacios, R., and Steinmetz, M. IL-3 dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocyte in vivo. Cell, 41: 727-734, 1985.
36. Nakamura, Y., Tokumoto, Y., and Nakauchi, H. Role of erythropoietin receptor for erythroid differentiation. Biochem. Biophys. Res. Commun., 218: 205-209, 1996.
37. Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matumoto, K., and Taniguchi, T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell, 70: 57-67, 1992.
38. Sato, N., Sakamaki, K., Terada, N., Arai, K., and Miyajima, A. Signal transduction by the high affinity GM-CSF receptor: two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J., 12: 4181-4189, 1993.
39. Leonard, M., Brice, M., Engel, J. D., and Papayannopoulou, T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood, 82: 1071-1079, 1993.
40. Weiss, M. J., and Orkin, S. H. GATA transcription factors: key regulators of hematopoiesis. Exp. Hematol., 23: 99-107, 1995.
41. Kamesaki, H., Michaud, G. Y., Irving, S. G., Suwabe, N., Kamesaki, S., Okuma, M., and Cossman, J. TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1. Blood, 87: 999-1005, 1996.
42. Koury, M. J., and Bondurant, M. C. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor. J. Cell Physiol., 137: 65-74, 1988.
43. Boyer, S. H., Bishop, T. R., Rogers, O. C., Noyes, A. N., Frelin, L. P., and Hobbs, S. Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood, 80: 2503-2512, 1992.
44. 1 phase of the cell cycle. Proc. Natl. Acad. Sci. USA, 92: 2869-2873, 1995.
45. L as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA, 94: 6939-6942, 1997.
46. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90: 405-413, 1997.
47. L and apopain in the control of erythropoiesis by erythropoietin. Blood, 90: 630-640, 1997.
48. Mufson, R. A., Szabo, J., and Eckert, D. Human IL-3 induction of c-jun in normal monocytes is independent of tyrosine kinase and involves protein kinase C. J. Immunol., 148: 1129-1135, 1992.
49. Adunyah, S., Unlap, T., Wagner, F., and Kraft, A. Regulation of c-jun expression and AP-1 enhancer activity by granulocyte-macrophage colony stimulating factor. J. Biol. Chem., 266: 5670-5675, 1991.
50. Rinaudo, M. S., Su, K., Falk, L. A., Haldar, S., and Mufson, R. A. Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood, 86: 80-88, 1995.
51. Li, Y., Davis, K. L., and Sytkowski, A. J. Protein kinase C-∈ is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. J. Biol. Chem., 271: 27025-27030, 1996.
52. Krosl, J., Damen, J. E., Krystal, G., and Humphries, R. K. Erythropoietin and interleukin-3 induce distinct events in erythropoietin receptor-expressing BA/F3 cells. Blood, 85: 50-56, 1995.
53. Todokoro, K., Watson, R. J., Higo, H., Anamura, H., Kuramochi, S., Yanagisawa, H., and Ikawa, Y. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc. Natl. Acad. Sci. USA, 85: 8900-8904, 1988.
54. Chern, Y., O'Hara, C., and Sytkowski, A. J. Induction of hemoglobin synthesis by downregulation of MYB protein with an antisense oligodeoxynucleotide. Blood, 78: 991-996, 1991.
55. Busfield, S. J., and Klinken, S. P. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction. Blood, 80: 412-419, 1992.
56. i-increasing agents cyclopiazonic acid and thapsigargin. J. Biol. Chem., 269: 8786-8791, 1994.
57. Melotti, P., and Calabretta, B. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. Blood, 87: 2221-2234, 1996.
58. Sparatore, B., Pessino, A., Patrone, M., Passalacqua, M., Melloni, E., and Pontremoli, S. Role of δ-PKC on the differentiation process of murine erythroleukemia cells. Biochem. Biophys. Res. Commun., 193: 220-227, 1993.
59. Pessino, A., Passalacqua, M., Sparatore, B., Patrone, M., Melloni, E., and Pontremoli, S. Antisense oligonucleotide inhibition of δ protein kinase C expression accelerates induced differentiation of murine erythroleukemia cells. Biochem. J., 312: 549-554, 1995.
60. Tsai, F-Y., and Orkin, S. H., Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood, 89: 3636-3643, 1997.
61. Briegel, K., Lim, K. C., Plank, C., Beug, H., Engel, J. D., and Zenke, M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev., 7; 1097-1109, 1993.
62. Chrétien, S., Varlet, P., Verdier, F., Gobert, S., Cartron, J-P., Gisselbrecht, S., Mayeux, P., and Lacombe, C. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STATS activation. EMBO J., 15: 4174-4181, 1996.
63. Tilbrook, P. A., Bittorf, T., Callus, B. A., Busfield, S. J., Ingley, E., and Klinken, S. P. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. Cell Growth Differ., 7: 511-520, 1996.
64. Pless, M., Norga, K., Carroll, M., Heim, M. H., D'Andrea, A. D., and Mathey-Prevot, B. Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STATS binding. Blood, 89: 3175-3185, 1997.
65. Hong, Y., Martin, J. F., Vainchenker, W., and Erusalimsky, J. D. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Blood, 87: 123-131, 1996.
66. Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J., 11: 3887-3895, 1992.
67. Shimamoto, T., Ohyashiki, J. H., Ohyashiki, K., Kawakubo, K., Kimura, N., Nakazawa, S., and Toyama, K. GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia. Leukemia (Baltimore), 8: 1176-1180, 1994.
68. Barbu, V., and Dautry, F. Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res., 17: 7115, 1989.
69. Nagata, K., Okano, Y., and Nozawa, Y. Protein kinase C isozymes in a human megakaryoblastic leukemia cell line, MEG-01 : possible involvement of the isozymes in the differentiation process of MEG-01 cells. Br. J. Haematol., 93: 762-771, 1996.
70. Chiba, S., Takahashi, T., Takeshita, K., Minowada, J., Yazaki, Y., Ruddle, F. H., and Hirai, H. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. Blood, 90: 97-104, 1997.
71. Muramatsu, M., Hayashi, T., Onishi, T., Sakai, M., Takai, K., and Kashiyama, T. Rapid isolation of nucleoli from detergent purified nuclei of various tumor and tissue culture cells. Exp. Cell Res., 88: 345-351, 1974.